The WA digital health sector now has its own dedicated commercialisation support. The WA Connected Health Commercialisation Initiative has launched! ANDHealth, Australia’s leading digital health commercialisation organisation, is excited to deliver the WA Connected Health Commercialisation Initiative, in collaboration with the WA Life Sciences Innovation Hub. The Initiative is designed to build the capability of WA […]
ANDHealth and Planet Innovation have partnered to deliver the BRIGHT Ideate program for early-stage digital health companies, in collaboration with the WA Life Sciences Innovation Hub. The BRIGHT framework has twice been voted Australia's Best Innovation Program by the AFR and will be the backbone of the seminar, supplemented by proven digital health experts from […]
Join ANDHealth for the third instalment in the WA Connected Health Commercialisation Initiative Expert Workshop Series! “The most significant bottleneck in the adoption of healthcare technology to date has been distribution. Over the last decade, generations of digital health companies have struggled to reach escape velocity—not because their products and services weren’t transformative, but because they […]
ANDHealth’s Masterclass: ACCELERATE Program is the only intensive accelerator program designed specifically for companies seeking to commercialise evidence-based digital health products. It is globally unique and engages with international industry leaders in a private, participant only forum. The interactive program features: • Workshop-style learning groups • Real-world case studies • Advanced business concepts and strategies […]
Join ANDHealth for the fourth instalment in the WA Connected Health Commercialisation Initiative Expert Workshop Series! We are joined by special international guest Lisa Suennen, CEO, Venture Valkyrie, based in California, who will deliver a comprehensive workshop on surviving due diligence in digital health. Firstly, Lisa will step us through the evolution of digital health over the […]
The Software as a Medical Device Specialisation course will help you navigate the market and regulatory landscapes for Software as a Medical Device (SAMD) products, develop skills in capital raising and crafting a robust go-to-market strategy and pitch deck. By the end of this course, you will understand how to: Identify your pathway to market in […]
Join ANDHealth and expert speakers from the TGA to hear an overview of the key changes in the updated SaMD regulations, and participate in a live Q&A session directly with the TGA. This joint TGA-ANDHealth initiative supports Australian SMEs to navigate the regulatory guidelines and compliance requirements for Software as a Medical Device (SaMD). This is an important session for […]
CUREator+ will provide SMEs (SMEs) with access to investment capital, commercial guidance, international expert networks, and hands-on support and mentorship to drive the translation and commercialisation of their opportunities. In addition to program oversight, SMEs will be supported to secure follow-on funding and facilitate their continued development. This program aims to support the development of: […]
An Overview: SaMD Regulation by the TGA Join ANDHealth and expert speakers from the TGA to hear an overview of the key changes in the updated SaMD regulations, and participate in a live Q&A session directly with the TGA. This joint TGA-ANDHealth initiative supports Australian SMEs to navigate the regulatory guidelines and compliance requirements for Software as a Medical Device […]
Supercharge Your US Expansion: Exclusive Webinar Series from ANDHealth Are you exploring US healthcare market opportunities or preparing for your first steps into the world’s largest health system? Don’t miss this exclusive four-part virtual series from ANDHealth, designed for digital and connected health innovators ready to accelerate international growth. What you’ll gain: Real-world advice and […]
ANDHealth+ is a commercialisation acceleration program for innovative digital and connected health technologies with demonstrable commercial and clinical impact potential. It is a national program that is designed to be delivered virtually, Australia-wide. All Australian SMEs which meet the eligibility criteria are encouraged to apply. The two-stage program supports proof-of-concept stage, evidence-based digital and connected […]
